Method for producing nucleic acid oligomer
AssigneeSumitomo Chemical Company, Limited
InventorsYuki Tanaka, Toshifumi Kano
Life of this patent
Estimating the term…
Abstract
The present invention provides a method for efficiently producing a nucleic acid oligomer. Specifically, the present invention provides a method for producing a nucleic acid oligomer represented by Formula (2), the method including a step of reacting a nucleic acid oligomer represented by Formula (1) with a dichloroacetic acid solution having a molar ratio of formaldehyde to dichloroacetic acid (formaldehyde mol/dichloroacetic acid mol) of 90×10−6 or less: wherein symbols have the meanings given in the description; wherein symbols have the meanings given in the description.
Claims24
A method for producing a nucleic acid oligomer represented by the following formula (2), the method comprising:
- reacting a nucleic acid oligomer represented by the following formula (1) with a dichloroacetic acid solution, wherein the dichloroacetic acid solution comprises dichloroacetic acid and formaldehyde, at a molar ratio of formaldehyde to dichloroacetic acid (formaldehyde mol/dichloroacetic acid mol) of 90×10−6 or less:
- wherein
- G2 represents a protecting group of a hydroxyl group,
- Ba is the same or different and each independently represents a nucleobase which may be protected with a protecting group,
- R1, R2 and R3 are the same or different and each independently represent a hydrogen atom or an alkoxy group,
- R is the same or different and each independently represents a protected hydroxyl group, a hydrogen atom, a fluorine atom, a methoxy group, a 2-methoxyethyl group, or an OQ′ group,
- Q′ is the same or different and each independently represents a methylene group bonded to a carbon atom at a 4′-position of ribose, an ethylene group bonded to a carbon atom at a 4′-position of ribose, or an ethylidene group bonded to a carbon atom at a 4′-position of ribose,
- Y is the same or different and each independently represents an oxygen atom or a sulfur atom,
- n represents an integer of from 1 to 200,
- W1 represents an OZ group and X1 represents an R group, or
- W1 represents an OV group, and X1 represents an OZ group,
- V represents a protecting group of a hydroxyl group,
- Z is a group having a structure including a solid support and a linking group, and
- when n is an integer of 2 or more, a non-nucleotide linker is optionally incorporated between respective nucleotides in the nucleic acid oligomer represented by the formula (1);
- and
- wherein
- G2, Ba, R, Y, X1, W1, and n are as in the formula (1), and
- a non-nucleotide linker is optionally incorporated between respective nucleotides in the nucleic acid oligomer represented by the formula (2).
A method for producing a nucleic acid oligomer represented by the following formula (2′), the method comprising:
- reacting a nucleic acid oligomer represented by the formula (1) with a dichloroacetic acid solution having a molar ratio of formaldehyde to dichloroacetic acid, formaldehyde mol/dichloroacetic acid mol, of 90×10−6 or less:
- wherein
- G2 represents a protecting group of a hydroxyl group,
- Ba is the same or different and each independently represents a nucleobase which optionally protected with a protecting group,
- R1, R2 and R3 are the same or different and each independently represent a hydrogen atom or an alkoxy group,
- R is the same or different and each independently represents a protected hydroxyl group, a hydrogen atom, a fluorine atom, a methoxy group, a 2-methoxyethyl group, or an OQ′ group,
- Q′ is the same or different and each independently represents a methylene group bonded to a carbon atom at a 4′-position of ribose, an ethylene group bonded to a carbon atom at a 4′-position of ribose, or an ethylidene group bonded to a carbon atom at a 4′-position of ribose,
- Y is the same or different and each independently represents an oxygen atom or a sulfur atom,
- n represents an integer of from 1 to 200,
- W1 represents an OZ group and X1 represents an R group, or
- W1 represents an OV group, and X1 represents an OZ group,
- V represents a protecting group of a hydroxyl group,
- Z is a group having a structure including a solid support and a linking group, and
- when n is an integer of 2 or more, a non-nucleotide linker is optionally incorporated between respective nucleotides in the nucleic acid oligomer represented by the formula (1);
- and
- wherein
- G2, Ba, R, Y, X1, W1, and n are as in the formula (1), and
- a non-nucleotide linker is optionally incorporated between respective nucleotides in the nucleic acid oligomer represented by the formula (2);
- removing a group represented by Z from the nucleic acid oligomer represented by the formula (2);
- and
- removing a protecting group of a hydroxyl group and a nucleobase:
- wherein
- Y and n are as in the formula (1),
- Be is the same or different and each independently represents a nucleobase,
- G4 is the same or different and each independently represents a hydrogen atom, an alkali metal ion, an ammonium ion, an alkylammonium ion, or a hydroxyalkylammonium ion,
- R′ is the same or different and each independently represents a hydroxyl group, a hydrogen atom, a fluorine atom, a methoxy group, a 2-methoxyethyl group, or an OQ′ group,
- Q′ is as in the formula (1),
- X3 and W3 each independently represent a hydroxyl group, or
- X3 represents an R′ group, and W3 represents a hydroxyl group.
A dichloroacetic acid solution, comprising:
- formaldehyde;
- and
- dichloroacetic acid,
- wherein a molar ratio of formaldehyde to dichloroacetic acid, formaldehyde mol/dichloroacetic acid mol, is 90×10−6 or less.
Dependencies are inferred from the claim text.